Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but necessary ...

The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...

The DNA testing kit company is also discontinuing new developments to its therapeutics program, which has been focused on ...

The genetic testing firm will also close its drug development arm. CEO Anne Wojcicki said the cuts are necessary to “focus on ...

In a significant move to stabilize its operations, 23andMe has announced the layoff of 200 employees, representing a ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

In the year since its hack, 23andMe has lost all of its value and most of its governing board — and somehow, things just keep ...